跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
M-DORZOLAMIDE-TIMOLOL - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
M-DORZOLAMIDE-TIMOLOL
Authorized
STANDARD
M-DORZOLAMIDE-TIMOLOL
mantra pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
19df3ded097d7c03
Company
mantra pharma inc
Type
Standard
Approval Details
Approval Id
19df3ded097d7c03
Drug Approval Canada Name
M-DORZOLAMIDE-TIMOLOL
Product Name
M-DORZOLAMIDE-TIMOLOL
Status
Marketed
Status Date
2023-11-13
Original Market Date
2023-11-13
Din
02537796
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Ophthalmic
Schedule
Prescription
Ahfs
52:40.12
Atc Original
S01ED51 TIMOLOL, COMBINATIONS
Atc Name
s 01 ed 51
Aig Number
0237301001
Company Name
mantra pharma inc
Company Address
1000 Rue Du Lux Suite 201, Brossard, Quebec, Canada, J4Y 0E3
Active Ingredients
DORZOLAMIDE (DORZOLAMIDE HYDROCHLORIDE)
20 MG / ML
TIMOLOL (TIMOLOL MALEATE)
5 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
19df3ded097d7c03
Type
Standard
Back to Health Canada Approvals